The Lebanon Healthcare Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Lebanon Healthcare Journal.

September 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

Press releases published on October 13, 2025

October 13, 2025

New Study Confirms Stress-Reduction Benefits of Natural Remedies’ Ashwa.30

GlobeNewswire

October 13, 2025

General Oncology to Present Preliminary Phase 1 Results from SHARON Trial in Patients with BRCA/PALB2-mutated Pancreatic and Breast Cancer at ESMO 2025

GlobeNewswire

October 13, 2025

Anaptys Announces Late-Breaking Oral Presentation of Complete Phase 2b Data for Rosnilimab in Rheumatoid Arthritis at Upcoming ACR Convergence 2025

GlobeNewswire

October 13, 2025

PacBio HiFi Technology Selected as Core Platform for South Korea’s National Pangenome Project

GlobeNewswire

October 13, 2025

Humanitarian Nonprofit Human Appeal USA to Host National Comedy Tour

GlobeNewswire

October 13, 2025

Palisade Bio Granted Canadian Patent Covering Composition of Lead Product Candidate PALI-2108

GlobeNewswire

October 13, 2025

Salarius Pharmaceuticals Regains Compliance with All Nasdaq Listing Requirements

GlobeNewswire

October 13, 2025

Ardelyx to Report Third Quarter 2025 Financial Results on October 30, 2025

GlobeNewswire

October 13, 2025

ProQR to Participate in Upcoming Investor Conferences in October 2025

GlobeNewswire

October 13, 2025

Nexalin Technology Expands Scientific Advisory Board with Appointment of Dr. Robert Rothstein to Support Alzheimer’s and Traumatic Brain Injury Programs

GlobeNewswire

October 13, 2025

Ardelyx Appoints Experienced Finance Executive, Sue Hohenleitner, as Chief Financial Officer

GlobeNewswire

October 13, 2025

Auron Therapeutics to Participate in the 8th Annual Targeted Protein Degradation & Induced Proximity Summit

GlobeNewswire

October 13, 2025

MannKind Announces U.S. FDA Accepts for Review its Supplemental Biologics License Application (sBLA) for Inhaled Insulin (Afrezza) in Children and Adolescents Aged 4-17 Years Living with Diabetes

GlobeNewswire

October 13, 2025

Evaxion to present a breadth of data from phase 2 trial with AI-designed personalized cancer vaccine EVX-01 at the ESMO Congress 2025

GlobeNewswire

October 13, 2025

SELLAS Life Sciences to Present In Vivo Preclinical Data Demonstrating Statistically Significant Survival Benefit of SLS009 in T-Cell Prolymphocytic Leukemia at the European Society for Medical Oncology (ESMO) Congress 2025

GlobeNewswire

October 13, 2025

Collegium to Celebrate 10-Year Anniversary with Nasdaq Opening Bell Ringing

GlobeNewswire

October 13, 2025

Hinge Bio Announces FDA Clearance of Investigational New Drug Application for HB2198, a Novel B cell-Depleting Agent, for Patients with Systemic Lupus Erythematosus and Lupus Nephritis

GlobeNewswire

October 13, 2025

HMNC Brain Health Presents New Analysis Supporting Rationale for Combining a Genetic Patient Selection Tool with a Vasopressin V1b Receptor Antagonist in the Treatment of Depression at ISCTM Conference in Amsterdam

GlobeNewswire

October 13, 2025

Cidara Therapeutics to Present Late-Breaking Clinical Phase 2 Data on CD388 at ID Week 2025

GlobeNewswire

October 13, 2025

Bringing Halloween Magic to Life for Children with Autism Spectrum Disorder and Sensory Sensitivities

GlobeNewswire